Immune Checkpoint Inhibitor Related Myositis/Myasthenia Gravis Overlap Syndrome Treated with Eculizumab

被引:0
|
作者
Hewitt, Sage
Wang, Danfeng
Poursheykhi, Meryim
Patel, Shaily
Shah, Shailee
机构
关键词
D O I
10.1212/01.wnl.0001051900.06940.ea
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S131 / S132
页数:2
相关论文
共 50 条
  • [21] Life-threatening immune checkpoint inhibitor-induced myocarditis and myasthenia gravis overlap syndrome treated with abatacept: a case report
    Wakefield, Chelby
    Shultz, Carl
    Patel, Brijesh
    Malla, Midhun
    BMJ CASE REPORTS, 2021, 14 (11)
  • [22] Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
    Verma, Neha
    Jaffer, Muhammad
    Pina, Yolanda
    Peguero, Edwin
    Mokhtari, Sepideh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [23] Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review
    Gao, Loulu
    Li, Xuemei
    Guo, Zhijun
    Tang, Lin
    Peng, Jieqiong
    Liu, Bo
    MEDICINE, 2022, 101 (49) : E32240
  • [24] IMMUNE CHECKPOINT INHIBITOR-RELATED MYASTHENIA GRAVIS: A CASE REPORT
    Agrawal, Simran
    Yeboah-Kordieh, Yvette
    Hedayati, Gilava
    Jaller, Alejandro
    Singh, Jasvinder
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [25] Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis
    Gullapalli, Manoja
    Arulprakash, Narenraj
    Safar, Mazin
    Kocurek, Emily
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [26] IMMUNE CHECKPOINT INHIBITOR-MEDIATED MYASTHENIA GRAVIS
    Ho, Adrienne K.
    Cooksley, Tim
    JOURNAL OF EMERGENCY MEDICINE, 2020, 59 (04): : 561 - 562
  • [27] Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
    Huang, Yi-Te
    Chen, Ya-Ping
    Lin, Wen-Chih
    Su, Wu-Chou
    Sun, Yuan-Ting
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [28] CONCURRENT MYASTHENIA GRAVIS, MYOCARDITIS, AND MYOSITIS SECONDARY TO IMMUNE CHECKPOINT INHIBITORS
    Rode, Shomita
    Reed, Mark
    Parker, William A.
    Johnson, Jeremy C.
    Kalanjeri, Satish
    CHEST, 2024, 166 (04) : 2693A - 2694A
  • [29] OVERLAP OF MYASTHENIA GRAVIS AND MYOSITIS IS A COMMON ETIOLOGY OF NEUROMUSCULAR WEAKNESS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY IN A MULTICENTER RETROSPECTIVE STUDY OF 15 PATIENTS
    Guidon, Amanda
    Raja, Shruti
    Dubey, Divyanshu
    Clement, Nathan
    Reynolds, Kerry
    Guptill, Jeffrey
    David, William
    MUSCLE & NERVE, 2018, 58 : S99 - S99
  • [30] Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review
    Siu, Derrick Ho Wai
    O'Neill, Robert Sean
    Harris, Carole A.
    Wang, Justine
    Ardolino, Luke
    Downton, Teesha
    Tong, Matthew
    Hong, Jun Hee
    Chin, Venessa
    Clingan, Philip R.
    Aghmesheh, Morteza
    Soudy, Hussein
    IMMUNOTHERAPY, 2022, 14 (07) : 511 - 520